ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Vitamin D supplementation extends life in mouse model of Huntington's disease

What’s Fenugreek Good For?

Omega-3 fatty acid stops known trigger of lupus

Print Page
Email Article

Symptom Relief of Major Depression in Less Than Two Hours with Experimental Medication

  [ 421 votes ]   [ Discuss This Article ]
By Editor • • August 25, 2006

A single very low intravenous dose of a medication historically employed for anesthesia – and experimentally for FM pain – can provide significant relief or remission of treatment-resistant major depression in less than two hours, according to a new study by the National Institute of Mental Health. Further, for 35 percent of the patients, the response to the single dose was sustained for at least one week. The patients who took part in this randomized, placebo-controlled, double-blind crossover trial had previously tried an average of six antidepressants without symptom relief.

These findings have potentially “enormous public health implications,” according to the NIMH. By comparison, most currently-used antidepressants require eight weeks to demonstrate benefits – if they work at all – for patients diagnosed with treatment-resistant major depression. And usually four to six weeks are required even for “more responsive” patients, the researchers explain.

The drug involved - Ketamine - corrects a chemical imbalance in the brain that interferes with the regulation of normal electrical flow between brain cells. It is able to act so much more swiftly than other antidepressants because it intervenes in the same mood-regulating chemical chain of events as they do, only several stages “downstream.”

However, because Ketamine has become known in club-drug circles for its “psychedelic” side effects since the 1960s, the NIMH researchers caution that an altered version of the drug will be necessary for use as an antidepressant, to avoid addiction or disorientation. And in the process, they believe, they’ll come closer to understanding why depression occurs in the first place – while possibly identifying biological markers that may aid in diagnosis.

The report on the NIMH trial, “A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression,” by Carlos A. Zarate, Jr., MD, et al., was published in the August 2006 issue of the Archives of General Psychiatry. See also the NIMH press release at

Implications regarding the mechanism of Fibromyalgia pain. In technical terms, Ketamine’s antidepressant quality is thought to result from its ability to block the brain protein N-methyl-D-aspartate (NMDA) receptor. Researchers believe that this same “NMDA antagonist” action may account for Ketamine’s ability to reduce some Fibromyalgia patients’ pain and tender point sensitivity, as demonstrated in various trials.1,2 The inference is that Fibromyalgia pain may result from “NMDA receptor activation in the spinal cord” – causing an increase in the neurons’ response to pain stimuli (“central sensitization”).3


1. Go to the archive to find an abstract of the article “Pain analysis in patients with Fibromyalgia (FM). Effects of intravenous morphine, lidocaine, & ketamine,” by J. Sorenson, et al., published in the November-December 1995 issue of the Scandinavian Journal of Rheumatology.

2. Go to the Immune archive to find an abstract of the article “Ketamine in chronic pain management: An evidence-based review,” by G. Hocking & M.J. Cousins, published in the December 2003 issue of the journal Anesthesia and Analgesia.

3. Go to to review an abstract of the article “Update on the neurophysiology of pain transmission and modulation: Focus on the NMDA-Receptor,” by G.J. Bennett, published in the January 2000 issue of the Journal of Pain Symptom Management.

Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Energy NADH™ 12.5mg Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
Priming Your Immune System for Cold & Flu Season Priming Your Immune System for Cold & Flu Season
Breaking Through the Mental Fog Breaking Through the Mental Fog
Why Berries Offer a Rainbow of Health Benefits Why Berries Offer a Rainbow of Health Benefits

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map